シングルユースバイオプロセス市場

出版：MarketsandMarkets

Single use Bioprocessing Market by Product (Media Bags and containers, Bioreactors, Mixers, Assemblies), Application (Cell Culture, Mixing, Storage, Filtration, Purification), End User (Biopharma Companies, CROs, CMOs) – Global Forecast 2026

–

–

シングルユースバイオプロセス市場　製品（メディアバッグおよびコンテナー、バイオリアクター、ミキサー、アセンブリ）、アプリケーション（細胞培養、混合、保管、ろ過、精製）、エンドユーザー（バイオ医薬品会社、CRO、CMO）

The global single-use bioprocessing market is expected to reach USD 20.8 billion by 2026 from USD 8.2 billion in 2021, at a CAGR of 20.5% during the forecast period. Single-use bioprocessing is a rapidly evolving technology used to develop disposable bioprocessing equipment and accessories to manufacturing biopharmaceutical molecules such as recombinant proteins, monoclonal antibodies, vaccines, and stem cells. Bioprocess utilizes living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind using single-use bioprocessing technology in the bioprocess is to decrease the cost associated with complicated steps such as cleaning, sterilization, and maintenance of steel-based bioreactor systems.

“The single-use media bags and containerssegment accounted for the highest growth rate in the single use bioprocessingmarket, byproduct, during the forecast period”
In 2020, the single-use media bags and containers segment accounted for the largest shareof the single use bioprocessing market, mainly because they provide a single-use disposable alternative to traditional glass and rigid plastic carboys in a large variety of bioprocess applications. They enhance process reliability as they reduce the risk of cross-contamination from batch to batch and from product to product. They also eliminate the time and expense of clean-in-place (CIP) & sterilization-in-place (SIP) operations, thus optimizing capacity utilization. The expanded application of single-use bags across biomanufacturing processes drives the market for single-use media bags.

“Filtrationsegment accounted for the largest share of the application segment”
In 2020, the filtration application accounted for the largest share.A single-use capsule filter, for instance, serves as an effective substitute for stainless steel housings that require the installation of filter elements. Considering that a fully integrated, single-use system, including the filter, bag, tubing, and other components, is manufactured and sterilized as one eliminates the contamination risks associated with aseptic connections during coupling. Single-use filtration systems also ensure that operators do not come in contact with cleaning solutions, cytotoxic fluids, or buffers with extreme pH.The single-use nature of this type of filtration system eliminates the need for system maintenance, cleaning and cleaning validation and avoids any possibility of contamination from product to product or batch to batch.

“Asia Pacific: The fastest-growing regionin thesingle use bioprocessingmarket”
Thesingle use bioprocessing market is segmented into North America, Europe, Asia Pacific,Latin America (LATAM) and Middle East and Africa (MEA). Significant investments by key market players, increasing government support, and developing R&D infrastructure are the major factors fueling the growth of the singleuse bioprocessing market in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%and Demand Side 20%
• By Designation: C-level – 25%, D-level – 20%, and Others – 55%
• By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%
Lists of Companies Profiled in the Report:
• Sartorius Stedim Biotech S. A. (France)
• Danaher Corporation (US)
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• Getinge AB (Sweden)
• Eppendorf AG (Germany)
• Corning (US)
• Entegris (US)
• Avantor (US)
• CESCO Bioengineering Co. Ltd. (Taiwan)
• Cellexus (UK)
• PBS Biotech, Inc. (US)
• Distek, Inc. (US)
• ABEC, Inc. (US)
• Able Corporation &Biott Corporation (Japan)
• G&G Technologies (US)
• Solida Biotech GmbH (Germany)
• Satake Chemical Equipment Mfg., Ltd. (Japan)
• Stobbe Pharma GmbH (Switzerland)
• Celltainer Biotech (Netherlands)
• Meissner Filtration roducts, Inc. (US)
• bbi-biotech GmbH (Germany)
• Pierre Guerin (France)
• Kuhner AG (Switzerland)
• OmniBRx Biotechnologies (India).
Research Coverage:
This report provides a detailed picture of thesingle use bioprocessing market. It aims at estimating the size and future growth potential of the market across different segments such as theproduct, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall singleuse bioprocessing marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers,restraints, challenges,trends,and opportunities.

目次

1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 31
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS 31
1.7 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH METHODOLOGY 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY SOURCES: SINGLE-USE BIOPROCESSING MARKET 33
2.2 MARKET SIZE ESTIMATION 34
FIGURE 2 MARKET SIZE ESTIMATION APPROACH: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) 34
FIGURE 3 SINGLE-USE BIOPROCESSING MARKET: FINAL MARKET (USD BILLION) 35
FIGURE 4 BREAKDOWN OF PRIMARIES: SINGLE-USE BIOPROCESSING MARKET 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 36
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY 36
2.3.1 KEY INDUSTRY INSIGHTS 38
2.3.2 RESEARCH ASSUMPTIONS 38
3 EXECUTIVE SUMMARY 40
FIGURE 6 MEDIA BAGS AND CONTAINERS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 40
FIGURE 7 FILTRATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET DURING THE FORECAST PERIOD 41
FIGURE 8 CROS AND CMOS TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET DURING THE FORECAST PERIOD 41
FIGURE 9 GEOGRAPHICAL SNAPSHOT: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING MARKET IN 2020 42
4 PREMIUM INSIGHTS 43
4.1 SINGLE-USE BIOPROCESSING MARKET OVERVIEW, 2021 VS. 2026 43
FIGURE 10 RISING DEMAND FOR BIOPHARMACEUTICALS IS A KEY DRIVER FOR
MARKET GROWTH 43
4.2 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT &
COUNTRY (2021) 44
FIGURE 11 MEDIA BAGS AND CONTAINERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021 44
4.3 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION 44
FIGURE 12 THE FILTRATION SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE SINGLE-USE BIOPROCESSING APPLICATIONS MARKET IN 2020 44
4.4 SINGLE-USE BIOPROCESSING MARKET, BY END USER 45
FIGURE 13 BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE END USERS SEGMENT IN 2020 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
FIGURE 14 SINGLE-USE BIOPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.1.1 DRIVERS 47
5.1.1.1 The growing demand for biopharmaceuticals 47
5.1.1.2 Reduced investments for single-use bioprocessing technologies 47
FIGURE 15 IMPACT ON VARIOUS PARAMETERS: SINGLE-USE SYSTEMS VS. STAINLESS STEEL SYSTEMS 47
5.1.1.3 Faster implementation and lower risk of product cross-contamination 48
5.1.2 RESTRAINTS 48
5.1.2.1 Issues related to leachables and extractables 48
TABLE 1 KEY EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS 49
5.1.3 OPPORTUNITIES 50
5.1.3.1 Emerging markets 50
5.1.3.2 Patent Expiry 50
FIGURE 16 US: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS 50
5.1.4 CHALLENGES 51
5.1.4.1 Waste disposal 51
TABLE 2 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS 51
5.1.4.2 Issues associated with scalability 51
5.2 PORTER’S FIVE FORCES ANALYSIS 52
FIGURE 17 PORTER’S FIVE FORCES ANALYSIS (2020) 52
5.2.1 THREAT FROM NEW ENTRANTS 52
5.2.2 THREAT FROM SUBSTITUTES 52
5.2.3 BARGAINING POWER OF SUPPLIERS 53
5.2.4 BARGAINING POWER OF BUYERS 53
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 53
5.3 VALUE CHAIN ANALYSIS 54
FIGURE 18 VALUE CHAIN ANALYSIS OF THE ECOSYSTEM OF SINGLE-USE BIOPROCESSING: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE 54

5.4 PRICING ANALYSIS 56
TABLE 3 AVERAGE SELLING PRICE OF SINGLE-USE BIOREACTORS BY REGION (2019) 56
5.5 TECHNOLOGICAL ANALYSIS 57
5.6 IMPACT OF COVID-19 OUTBREAK ON THE SINGLE-USE BIOPROCESSING MARKET 57
6 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT 59
6.1 INTRODUCTION 60
TABLE 4 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 60
TABLE 5 SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 60
6.2 SINGLE-USE MEDIA BAGS AND CONTAINERS 61
6.2.1 EXPANDED APPLICATIONS OF SINGLE-USE BAGS ACROSS BIOPROCESSING OPERATIONS TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT 61
TABLE 6 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION,
2017–2020 (USD MILLION) 61
TABLE 7 SINGLE-USE MEDIA BAGS AND CONTAINERS, BY REGION,
2021–2026 (USD MILLION) 62
TABLE 8 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS,
BY COUNTRY, 2017–2020 (USD MILLION) 62
TABLE 9 NORTH AMERICA: SINGLE-USE MEDIA BAGS AND CONTAINERS,
BY COUNTRY, 2021–2026 (USD MILLION) 62
TABLE 10 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY,
2017–2020 (USD MILLION) 63
TABLE 11 EUROPE: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY,
2021–2026 (USD MILLION) 63
TABLE 12 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2017–2020 (USD MILLION) 63
TABLE 13 ASIA PACIFIC: SINGLE-USE MEDIA BAGS AND CONTAINERS, BY COUNTRY, 2021–2026 (USD MILLION) 64
6.3 SINGLE-USE ASSEMBLIES 64
6.3.1 REDUCED RISK OF CONTAMINATION HAS PROPELLED THE DEMAND FOR SINGLE-USE ASSEMBLIES 64
TABLE 14 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2017–2020 (USD MILLION) 65
TABLE 15 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2021–2026 (USD MILLION) 65
TABLE 16 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 65
TABLE 17 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 66
TABLE 18 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 66
TABLE 19 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 66
TABLE 20 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 67
TABLE 21 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 67
6.4 SINGLE-USE BIOREACTORS 67
6.4.1 SINGLE-USE BIOREACTOR SYSTEMS OFFER GREAT FLEXIBILITY OF OPERATIONS 67
TABLE 22 SINGLE-USE BIOREACTORS MARKET, BY REGION,
2017–2020 (USD MILLION) 68
TABLE 23 SINGLE-USE BIOREACTORS MARKET, BY REGION,
2021–2026 (USD MILLION) 68
TABLE 24 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 68
TABLE 25 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 69
TABLE 26 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 69
TABLE 27 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 69
TABLE 28 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 70
TABLE 29 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 70
6.5 DISPOSABLE MIXERS 70
6.5.1 DISPOSABLE MIXERS OFFER REDUCED RISK OF CROSS CONTAMINATION WHICH DRIVES THE GROWTH OF THIS SEGMENT 70
TABLE 30 DISPOSABLE MIXERS MARKET, BY REGION, 2017–2020 (USD MILLION) 71
TABLE 31 DISPOSABLE MIXERS MARKET, BY REGION, 2021–2026 (USD MILLION) 71
TABLE 32 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 71
TABLE 33 NORTH AMERICA: DISPOSABLE MIXERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 72
TABLE 34 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 72
TABLE 35 EUROPE: DISPOSABLE MIXERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 72
TABLE 36 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 72
TABLE 37 ASIA PACIFIC: DISPOSABLE MIXERS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 73
6.6 OTHER PRODUCTS 73
TABLE 38 OTHER PRODUCTS MARKET, BY REGION, 2017–2020 (USD MILLION) 73
TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION) 74
TABLE 40 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 74
TABLE 41 NORTH AMERICA: OTHER PRODUCTS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 74
TABLE 42 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 74
TABLE 43 EUROPE: OTHER PRODUCTS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 75
TABLE 44 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 75
TABLE 45 ASIA PACIFIC: OTHER PRODUCTS MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 75
7 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION 76
7.1 INTRODUCTION 77
TABLE 46 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 77
TABLE 47 SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 77
7.2 FILTRATION 78
TABLE 48 FILTRATION APPLICATION, BY REGION, 2017–2020 (USD MILLION) 78
TABLE 49 FILTRATION APPLICATION, BY REGION, 2021–2026 (USD MILLION) 78
TABLE 50 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 79
TABLE 51 NORTH AMERICA: FILTRATION APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 79
TABLE 52 EUROPE: FILTRATION APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 79
TABLE 53 EUROPE: FILTRATION APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 79
TABLE 54 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 80
TABLE 55 ASIA PACIFIC: FILTRATION APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 80
7.3 STORAGE 80
7.3.1 SINGLE-USE STORAGE SYSTEMS OFFER COST SAVINGS ON STERILIZATION PROCESS 80
TABLE 56 STORAGE APPLICATION, BY REGION, 2017–2020 (USD MILLION) 80
TABLE 57 STORAGE APPLICATION, BY REGION, 2021–2026 (USD MILLION) 81
TABLE 58 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 81
TABLE 59 NORTH AMERICA: STORAGE APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 81
TABLE 60 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION) 81
TABLE 61 EUROPE: STORAGE APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION) 82
TABLE 62 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 82
TABLE 63 ASIA PACIFIC: STORAGE APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 82
7.4 CELL CULTURE 83
7.4.1 SINGLE-USE CELL CULTURE PRODUCTS OFFER REDUCED RISK OF CONTAMINATION 83
TABLE 64 CELL CULTURE APPLICATION, BY REGION, 2017–2020 (USD MILLION) 83
TABLE 65 CELL CULTURE APPLICATION, BY REGION, 2021–2026 (USD MILLION) 83
TABLE 66 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 83
TABLE 67 NORTH AMERICA: CELL CULTURE APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 84
TABLE 68 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 84
TABLE 69 EUROPE: CELL CULTURE APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 84
TABLE 70 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 84
TABLE 71 ASIA PACIFIC: CELL CULTURE APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 85
7.5 MIXING 85
7.5.1 DISPOSABLE MIXING SYSTEMS ARE COST-EFFICIENT, PREVENTING CLEANING AND STERILIZATION CHARGES 85
TABLE 72 MIXING APPLICATION, BY REGION, 2017–2020 (USD MILLION) 85
TABLE 73 MIXING APPLICATION, BY REGION, 2021–2026 (USD MILLION) 86
TABLE 74 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 86
TABLE 75 NORTH AMERICA: MIXING APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 86
TABLE 76 EUROPE: MIXING APPLICATION, BY COUNTRY, 2017–2020 (USD MILLION) 86
TABLE 77 EUROPE: MIXING APPLICATION, BY COUNTRY, 2021–2026 (USD MILLION) 87
TABLE 78 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 87
TABLE 79 ASIA PACIFIC: MIXING APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 87
7.6 PURIFICATION 88
7.6.1 SINGLE-USE PURIFICATION PRODUCTS ARE INCREASINGLY IN DEMAND OWING TO FLEXIBILITY OF USE 88
TABLE 80 PURIFICATION APPLICATION, BY REGION, 2017–2020 (USD MILLION) 88
TABLE 81 PURIFICATION APPLICATION, BY REGION, 2021–2026 (USD MILLION) 88
TABLE 82 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 89
TABLE 83 NORTH AMERICA: PURIFICATION APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 89
TABLE 84 EUROPE: PURIFICATION APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 89
TABLE 85 EUROPE: PURIFICATION APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 89
TABLE 86 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY,
2017–2020 (USD MILLION) 90
TABLE 87 ASIA PACIFIC: PURIFICATION APPLICATION, BY COUNTRY,
2021–2026 (USD MILLION) 90

8 SINGLE-USE BIOPROCESSING MARKET, BY END USER 91
8.1 INTRODUCTION 92
TABLE 88 SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 92
TABLE 89 SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 92
8.2 BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES 93
8.2.1 INCREASING PHARMACEUTICAL R&D SPENDING IS DRIVING THE DEMAND FOR SINGLE-USE BIOPROCESSING EQUIPMENT IN THIS END-USER SEGMENT 93
TABLE 90 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2017–2020 (USD MILLION) 93
TABLE 91 SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2021–2026 (USD MILLION) 94
TABLE 92 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION) 94
TABLE 93 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION) 94
TABLE 94 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION) 95
TABLE 95 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION) 95
TABLE 96 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES,
BY COUNTRY, 2017–2020 (USD MILLION) 95
TABLE 97 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION) 96
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) 96
8.3.1 INCREASING OUTSOURCING OF R&D SERVICES BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO SUPPORT THE MARKET GROWTH OF CROS AND CMOS 96
TABLE 98 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2017–2020 (USD MILLION) 97
TABLE 99 SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY REGION, 2021–2026 (USD MILLION) 97
TABLE 100 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION) 97
TABLE 101 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2026 (USD MILLION) 98
TABLE 102 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS,
BY COUNTRY, 2017–2020 (USD MILLION) 98
TABLE 103 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS,
BY COUNTRY, 2021–2026 (USD MILLION) 98
TABLE 104 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS & CMOS, BY COUNTRY, 2017–2020 (USD MILLION) 99
TABLE 105 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR CROS &
CMOS, BY COUNTRY, 2021–2026 (USD MILLION) 99
8.4 ACADEMIC & RESEARCH INSTITUTES 99
8.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES
TO DRIVE THE MARKET GROWTH 99
TABLE 106 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION) 100
TABLE 107 SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION) 100
TABLE 108 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION) 100
TABLE 109 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION) 101
TABLE 110 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION) 101
TABLE 111 EUROPE: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION) 101
TABLE 112 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION) 102
TABLE 113 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION) 102
9 SINGLE-USE BIOPROCESSING MARKET, BY REGION 103
9.1 INTRODUCTION 104
FIGURE 19 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 104
TABLE 114 SINGLE-USE BIOPROCESSING MARKET, BY REGION,
2017–2020 (USD MILLION) 105
TABLE 115 SINGLE-USE BIOPROCESSING MARKET, BY REGION,
2021–2026 (USD MILLION) 105
9.2 NORTH AMERICA 105
FIGURE 20 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT 106
TABLE 116 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 106
TABLE 117 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 107
TABLE 118 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 107
TABLE 119 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2021–2026 (USD MILLION) 107
TABLE 120 NORTH AMERICA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION, 2017–2020 (USD MILLION) 108
9.2.1 US 109
9.2.1.1 The growing focus on biopharmaceutical production in the US drives the market growth 109
TABLE 124 US: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 110
9.2.2 CANADA 112
9.2.2.1 The increasing incidences of lifestyle diseases such as cancer drive the market growth for biologics in Canada 112
TABLE 130 CANADA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 112
9.3 EUROPE 114
TABLE 136 EUROPE: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 114
9.3.1 GERMANY 117
9.3.1.1 Increasing adoption of single-use bioprocessing equipment by biopharma and CDMO companies to drive the market growth 117
TABLE 144 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 117
TABLE 145 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 118
TABLE 146 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 118
TABLE 147 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 118
TABLE 148 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 119
TABLE 149 GERMANY: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 119
9.3.2 UK 119
9.3.2.1 Rising government support for biotech companies to propel the demand for advanced technologies in the UK 119
TABLE 150 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 120
TABLE 151 UK: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 120
TABLE 152 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 120
TABLE 153 UK: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 121
TABLE 154 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 121
TABLE 155 UK: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 121
9.3.3 FRANCE 122
9.3.3.1 Increasing investments in life sciences R&D infrastructure development to drive the market growth in France 122
TABLE 156 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 122
TABLE 157 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 122
TABLE 158 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 123
TABLE 159 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 123
TABLE 160 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 123
TABLE 161 FRANCE: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 124
9.3.4 REST OF EUROPE (ROE) 124
TABLE 162 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 124
TABLE 163 ROE: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 125
TABLE 164 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 125
TABLE 165 ROE: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 125
TABLE 166 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 126
TABLE 167 ROE: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 126
9.4 ASIA PACIFIC 126
TABLE 168 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 127
FIGURE 21 ASIA PACIFIC: SINGLE-USE BIOPROCESSING MARKET SNAPSHOT 128
9.4.1 CHINA 131
9.4.1.1 Government support and significant private investments to drive the market growth in China 131
TABLE 176 CHINA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 131
9.4.2 JAPAN 133
9.4.2.1 Increasing biomanufacturing investments to favor the market growth 133
TABLE 182 JAPAN: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 133
9.4.3 INDIA 135
9.4.3.1 Low manufacturing and labor costs make India a lucrative country for single-use bioprocessing equipment manufacturers 135
TABLE 188 INDIA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 136
9.4.4 REST OF ASIA PACIFIC 138
TABLE 194 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 138
TABLE 195 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 138
TABLE 196 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 139
TABLE 197 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 139
TABLE 198 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 139
TABLE 199 ROAPAC: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 140
9.5 LATIN AMERICA (LATAM) 140
9.5.1 BRAZIL ACCOUNTS FOR THE LARGEST SHARE OF THE LATAM REGION FOR SINGLE-USE BIOPROCESSING IN 2020 140
TABLE 200 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 140
TABLE 201 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 141
TABLE 202 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 141
TABLE 203 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 141
TABLE 204 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 142
TABLE 205 LATAM: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 142
9.6 MIDDLE EAST AND AFRICA (MEA) 142
9.6.1 THE GROWTH OF THE BIOTECHNOLOGY INDUSTRY IN THIS REGION DRIVES THE WIDE ADOPTION OF SINGLE-USE BIOPROCESSING PRODUCTS 142
TABLE 206 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 143
TABLE 207 MEA: SINGLE-USE BIOPROCESSING MARKET, BY PRODUCT,
2021–2026 (USD MILLION) 143
TABLE 208 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2017–2020 (USD MILLION) 143
TABLE 209 MEA: SINGLE-USE BIOPROCESSING MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 144
TABLE 210 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 144
TABLE 211 MEA: SINGLE-USE BIOPROCESSING MARKET, BY END USER,
2021–2026 (USD MILLION) 144
10 COMPETITIVE LANDSCAPE 145
10.1 MARKET EVALUATION FRAMEWORK 145
10.2 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION QUADRANT 145
10.2.1 STARS 145
10.2.2 EMERGING LEADERS 145
10.2.3 PERVASIVE 146
10.2.4 PARTICIPANTS 146
FIGURE 22 GLOBAL SINGLE-USE BIOPROCESSING MARKET: COMPANY EVALUATION MATRIX, 2020 146
10.3 MARKET RANK ANALYSIS 147
FIGURE 23 SINGLE-USE BIOPROCESSING MARKET: MARKET RANKING OF KEY PLAYERS (2020) 147
10.4 COMPETITIVE SCENARIO 148
10.4.1 KEY PRODUCT LAUNCHES 148
10.4.2 KEY ACQUISITIONS 148

10.4.3 KEY PARTNERSHIPS AND AGREEMENTS 149
10.4.4 KEY EXPANSIONS 149
11 COMPANY PROFILES 151
(Business overview, Products offered, Recent Developments,SWOT Analysis, MNM view)*
11.1 SARTORIUS STEDIM BIOTECH 151
TABLE 212 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 151
FIGURE 24 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2020) 152
11.2 DANAHER CORPORATION 155
TABLE 213 DANAHER CORPORATION: BUSINESS OVERVIEW 155
FIGURE 25 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 156
11.3 THERMO FISHER SCIENTIFIC 160
TABLE 214 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 160
FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 161
11.4 MERCK KGAA 164
TABLE 215 MERCK KGAA: BUSINESS OVERVIEW 164
FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2020) 165
11.5 GETINGE AB 168
TABLE 216 GETINGE AB: BUSINESS OVERVIEW 168
FIGURE 28 GETINGE AB: COMPANY SNAPSHOT (2020) 169
11.6 EPPENDORF AG 171
TABLE 217 EPPENDORF AG: BUSINESS OVERVIEW 171
FIGURE 29 EPPENDORF: COMPANY SNAPSHOT (2020) 172
11.7 CORNING 174
TABLE 218 CORNING: BUSINESS OVERVIEW 174
FIGURE 30 CORNING COMPANY SNAPSHOT (2020) 175
11.8 ENTEGRIS 176
TABLE 219 ENTEGRIS: BUSINESS OVERVIEW 176
FIGURE 31 ENTEGRIS COMPANY SNAPSHOT (2020) 177
11.9 AVANTOR 179
TABLE 220 AVANTOR: BUSINESS OVERVIEW 179
FIGURE 32 AVANTOR: COMPANY SNAPSHOT (2020) 180
11.10 CESCO BIOENGINEERING CO., LTD. 182
TABLE 221 CESCO BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW 182
11.11 CELLEXUS 183
TABLE 222 CELLEXUS: BUSINESS OVERVIEW 183
11.12 PBS BIOTECH, INC. 184
TABLE 223 PBS BIOTECH, INC.: BUSINESS OVERVIEW 184
11.13 DISTEK, INC. 185
TABLE 224 DISTEK, INC.: BUSINESS OVERVIEW 185
11.14 ABEC, INC. 186
TABLE 225 ABEC INC.: BUSINESS OVERVIEW 186
11.15 ABLE CORPORATION & BIOTT CORPORATION 188
TABLE 226 ABLE CORPORATION & BIOTT CORPORATION: BUSINESS OVERVIEW 188
11.16 G&G TECHNOLOGIES, INC. 189
TABLE 227 G&G TECHNOLOGIES INC.: BUSINESS OVERVIEW 189
11.17 SOLIDA BIOTECH GMBH 190
TABLE 228 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW 190
11.18 SATAKE CHEMICAL EQUIPMENT MFG., LTD. 191
TABLE 229 SATAKE CHEMICAL EQUIPMENT MFG. LTD: BUSINESS OVERVIEW 191
11.19 STOBBE PHARMA GMBH 192
TABLE 230 STOBBE PHARMA GMBH: BUSINESS OVERVIEW 192
11.20 CELLTAINER BIOTECH BV 194
TABLE 231 CELLTAINER BIOTECH BV: BUSINESS OVERVIEW 194
11.21 MEISSNER FILTRATION PRODUCTS, INC. 195
TABLE 232 MEISSNER FILTRATION PRODUCTS INC.: BUSINESS OVERVIEW 195
11.22 BBI-BIOTECH 196
TABLE 233 BBI BIOTECH: BUSINESS OVERVIEW 196
11.23 PIERRE GUÉRIN 197
TABLE 234 PIERRE GUERIN: BUSINESS OVERVIEW 197
11.24 KUHNER AG 198
TABLE 235 KUHNER AG: BUSINESS OVERVIEW 198
11.25 OMNIBRX BIOTECHNOLOGIES 199
*Details on Business overview, Products offered, Recent Developments, SWOT Analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX 200
12.1 DISCUSSION GUIDE 200
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 204
12.3 AVAILABLE CUSTOMIZATIONS 206
12.4 RELATED REPORTS 206
12.5 AUTHOR DETAILS 207

お問合せフォーム